3MLT image
Deposition Date 2010-04-18
Release Date 2010-07-14
Last Version Date 2024-11-06
Entry Detail
PDB ID:
3MLT
Keywords:
Title:
Crystal structure of anti-HIV-1 V3 Fab 2557 in complex with a UG1033 V3 peptide
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.49 Å
R-Value Free:
0.28
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain
Chain IDs:B (auth: H), E (auth: B), H (auth: E), J (auth: I)
Chain Length:226
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain
Chain IDs:A (auth: L), D (auth: A), G (auth: D), I (auth: G)
Chain Length:219
Number of Molecules:4
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:HIV-1 gp120 third variable region (V3) crown
Gene (Uniprot):env
Chain IDs:C (auth: P), F (auth: C)
Chain Length:23
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1
Primary Citation
Conserved structural elements in the V3 crown of HIV-1 gp120.
Nat.Struct.Mol.Biol. 17 955 961 (2010)
PMID: 20622876 DOI: 10.1038/nsmb.1861

Abstact

Binding of the third variable region (V3) of the HIV-1 envelope glycoprotein gp120 to the cell-surface coreceptors CCR5 or CXCR4 during viral entry suggests that there are conserved structural elements in this sequence-variable region. These conserved elements could serve as epitopes to be targeted by a vaccine against HIV-1. Here we perform a systematic structural analysis of representative human anti-V3 monoclonal antibodies in complex with V3 peptides, revealing that the crown of V3 has four conserved structural elements: an arch, a band, a hydrophobic core and the peptide backbone. These are either unaffected by or are subject to minimal sequence variation. As these regions are targeted by cross-clade neutralizing human antibodies, they provide a blueprint for the design of vaccine immunogens that could elicit broadly cross-reactive protective antibodies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures